Navigation Links
German High Court Rules in Favor of AmniSure® as New European Guidelines Published
Date:3/4/2011

KARLSRUHE, Germany, March 4, 2011 /PRNewswire/ -- The High Court of Germany (Bundesgerichtshof) handed down a final ruling in favor of AmniSure® International, LLC in its dispute with the Finnish company Medix Biochemica. The court upheld the German Patent Court's ruling that the patent associated with Medix's ActimPROM test is null and void due to its lack of an inventive step. Medix is expected to pay AmniSure® an undisclosed amount to be determined by the courts.

"We are extremely pleased with the decision of the German High Court," said Dr. Michael Friedman, President and CEO of AmniSure® International. "The Court's decision coincided with the publication of the new peer-reviewed Guidelines of the European Association of Perinatal Medicine, which hailed the AmniSure® test as the 'most useful tool' and the 'most accurate bedside test' for diagnosing ruptured fetal membranes(1). The Court's decision closes a chapter for us by bringing a seven-year-long litigation, initiated by Medix, to its rightful conclusion. The publication of the European Guidelines, meanwhile, opens a new chapter for us by establishing the AmniSure® test as the new benchmark for diagnosing ruptured fetal membranes."

(1) The Journal of Maternal-Fetal and Neonatal Medicine, March 2011. ISSN 1476-7058

About AmniSure® International, LLCAmniSure® International, LLC (http://www.amnisure.com) is a medical device company that operates internationally with headquarters in Boston, MA. AmniSure® International pioneered a rapid diagnostic device, AmniSure® ROM Test, which solves a long-standing problem in obstetrics and is rapidly becoming a new global standard in maternal fetal medicine. Contact:info@amnisure.com  617-234-4441 Tel.This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>

SOURCE AmniSure International, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally
2. Mindray Medical to Exhibit at MEDICA 2010 in Dusseldorf, Germany from November 17- 20, 2010
3. Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
4. Diplomat Specialty Pharmacy Launches Diplomat University - Hires Jennifer Hagerman, PharmD, Pharmacy Professor
5. Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer
6. Ziehm Imaging Provides Germanys Federal Armed Forces (Bundeswehr) With Mobile X-Ray Systems
7. WATCHMAN® Receives German Reimbursement Coverage
8. ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firms Growing Client Base in Germany
9. Otix Global, Inc. to Discontinue German Operations
10. German District Court Finds RENASYS™ GO NPWT System Non-infringing
11. Dune Medical Devices Announces Positive Interim Results From EU MarginProbe™ Study Presented at German Breast Cancer Society Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):